CGRP
CGRP (calcitonin gene related peptide) is a potent peptide vasodilator and can function in the transmission of pain.
Products Related to CGRP (40)
- GC66408FremanezumabCAS: 1655501-53-3Purity: >95.00%
Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research.
- GC68821Cagrilintide acetatePurity: >99.00%
Cagrilintide acetate is a non-selective AMYR/CTR agonist and long-acting acylated amylin analogue. Cagrilintide acetate causes dose-dependent reduction in food intake and significant weight loss. It can be used for research on obesity.
- GC69077EptinezumabCAS: 1644539-04-7Purity: >99.00%
Eptinezumab is a human monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and blocks its binding to receptors. Eptinezumab can be used for the prevention of migraine headaches in adults.
- GC72093α-CGRP (mouse, rat) (TFA)Purity: >99.00%
α-CGRP (mouse, rat) TFA, a neuropeptide (calcitonin gene-related peptide (CGRP)) mainly expressed in neuromuscular junction, is a potent vasodilator.
- GC72110α-CGRP(human) TFAPurity: >98.00%
α-CGRP(human) TFA is a regulatory neuropeptide of 37 amino acids.
- GC72190CagrilintideCAS: 1415456-99-3Purity: >98.00%
Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist.
- GC72813(3R,5R,6S)-AtogepantPurity: >99.00%
(3R,5R,6S)-Atogepant ((3R,5R,6S)-MK-8031) is the enantiomer of Atogepant.
- GC74300β-CGRP (mouse)Purity: >99.50%
β-CGRP (mouse) is a calcitonin gene-related peptide that induces vasodilation.
- GC79274CTR/AMYR modulator-2CAS: 3108095-52-6Purity: >98.00%
CTR/AMYR modulator-2 is a dual agonist of human amylin receptor 3 ( AMY3R ) and calcitonin receptor ( CTR ).
- GC79279CLR/RAMP3-receptor antagonist-1CAS: 2252341-45-8Purity: >98%
CLR/RAMP3-receptor antagonist-1 is a selective antagonist of the CLR/RAMP3 receptor ( CLR/RAMP3, AM 2 receptor ), with pIC 50 values of 5.86, 9.21 and 9.07 against AM 1 (CLR/RAMP2), AM 2 (CLR/RAMP3) and CGRP (CLR/RAMP1) receptors, respectively.
- GC79281Adrenotensin (human) TFAPurity: >99.00%
Adrenotensin (human) (Pro-ADM-153-185 (human)) TFA is a 153-185 fragment of precursor peptide of Adrenomedullin.
- GC79282CTR/AMYR modulator-1CAS: 3097482-67-9Purity: >99.50%
CTR/AMYR modulator-1 is a calcitonin receptor/amylin receptor modulator.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC66408 | Fremanezumab | 1655501-53-3 | >95.00% | |
Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research. | ||||
| GC68821 | Cagrilintide acetate | - | >99.00% | |
Cagrilintide acetate is a non-selective AMYR/CTR agonist and long-acting acylated amylin analogue. Cagrilintide acetate causes dose-dependent reduction in food intake and significant weight loss. It can be used for research on obesity. | ||||
| GC69077 | Eptinezumab | 1644539-04-7 | >99.00% | |
Eptinezumab is a human monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and blocks its binding to receptors. Eptinezumab can be used for the prevention of migraine headaches in adults. | ||||
| GC69081 | Erenumab | 1582205-90-0 | >97.00% | |
Erenumab is a fully human monoclonal antibody that inhibits the calcitonin gene-related peptide (CGRP) receptor. It can be used for preventing episodic migraines. | ||||
| GC72093 | α-CGRP (mouse, rat) (TFA) | - | >99.00% | |
α-CGRP (mouse, rat) TFA, a neuropeptide (calcitonin gene-related peptide (CGRP)) mainly expressed in neuromuscular junction, is a potent vasodilator. | ||||
| GC72110 | α-CGRP(human) TFA | - | >98.00% | |
α-CGRP(human) TFA is a regulatory neuropeptide of 37 amino acids. | ||||
| GC72190 | Cagrilintide | 1415456-99-3 | >98.00% | |
Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. | ||||
| GC72813 | (3R,5R,6S)-Atogepant | - | >99.00% | |
(3R,5R,6S)-Atogepant ((3R,5R,6S)-MK-8031) is the enantiomer of Atogepant. | ||||
| GC74300 | β-CGRP (mouse) | - | >99.50% | |
β-CGRP (mouse) is a calcitonin gene-related peptide that induces vasodilation. | ||||
| GC79274 | CTR/AMYR modulator-2 | 3108095-52-6 | >98.00% | |
CTR/AMYR modulator-2 is a dual agonist of human amylin receptor 3 ( AMY3R ) and calcitonin receptor ( CTR ). | ||||
| GC79275 | KBP-089 | 1776112-67-4 | >99.00% | |
KBP-089 is a dual Amylin and Calcitonin Receptor agonist. | ||||
| GC79279 | CLR/RAMP3-receptor antagonist-1 | 2252341-45-8 | >98% | |
CLR/RAMP3-receptor antagonist-1 is a selective antagonist of the CLR/RAMP3 receptor ( CLR/RAMP3, AM 2 receptor ), with pIC 50 values of 5.86, 9.21 and 9.07 against AM 1 (CLR/RAMP2), AM 2 (CLR/RAMP3) and CGRP (CLR/RAMP1) receptors, respectively. | ||||
| GC79280 | Talogreptide vizaxetan | 1186600-65-6 | >98.00% | |
RM2 is a GRPr antagonist. | ||||
| GC79281 | Adrenotensin (human) TFA | - | >99.00% | |
Adrenotensin (human) (Pro-ADM-153-185 (human)) TFA is a 153-185 fragment of precursor peptide of Adrenomedullin. | ||||
| GC79282 | CTR/AMYR modulator-1 | 3097482-67-9 | >99.50% | |
CTR/AMYR modulator-1 is a calcitonin receptor/amylin receptor modulator. | ||||
| GC81401 | DD04107 | 1202877-06-2 | >99.50% | |
DD04107 is a neuronal exocytosis inhibitor with a rat Syt1-C2B domain binding K d of 2.4 μM. | ||||
